Colorectal Cancer Screening Outreach (NCT07345676)

🧪 Interventions in This Study

• Bundled messaging intervention (BEHAVIORAL)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Cornell Scott Hill Health — New Haven, Connecticut

📞 Contact the Study Coordinator

Phone: (203) 737-1024

Email: ilana.richman@yale.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Colo-rectal Cancer

• EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer — Buffalo, New York
• Decision Counseling and Follow-up for Shield+ Patients — Philadelphia, Pennsylvania
• Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study — Boston, Massachusetts
• A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE) — Gainesville, Florida
• Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery — Sacramento, California

Explore by condition: All Colo-rectal Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.